This compound belongs to the class of organic compounds known as pyridinylpiperazines. These are compounds containing a pyridinylpiperazine skeleton, which consists of a pyridine linked (not fused) to a piperazine by a bond by a single bond that is not part of a ring.
External Descriptors
Not available
1. Djoumbou Feunang Y, Eisner R, Knox C, Chepelev L, Hastings J, Owen G, Fahy E, Steinbeck C, Subramanian S, Bolton E, Greiner R, and Wishart DS. ClassyFire: Automated Chemical Classification With A Comprehensive, Computable Taxonomy. Journal of Cheminformatics, 2016, 8:61.
Certificati (CoA, COO, BSE/TSE e tabella di analisi)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Proprietà chimiche e fisiche
Peso molecolare
216.280 g/mol
XLogP3
1.200
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
2
Exact Mass
216.137 Da
Monoisotopic Mass
216.137 Da
Topological Polar Surface Area
43.200 Ų
Heavy Atom Count
16
Formal Charge
0
Complexity
261.000
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
The total count of all stereochemical bonds
0
Covalently-Bonded Unit Count
1
Calcolatori di soluzioni
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
Recensioni
Recensioni dei clienti
Application Protocols
No assay-specific or bioanalytical protocols are provided for this item.
General laboratory guidance (research context only):
Stock preparation: dissolve in dry DMSO to prepare 10–100 mM stocks; vortex and mild heat (≤40 °C) if needed. For aqueous use, convert to an acid salt and filter sterilize (0.22 µm) if required.
Analytical QC: verify identity/purity by LC/MS and 1H NMR before use in critical experiments. Record retention time and MS data for future lots.
Purification: for silica gel chromatography of basic compounds, use 0.5–2% Et3N in eluent to reduce tailing, or use reversed-phase methods with volatile buffers for LC/MS compatibility.
For application-specific SOPs (e.g., screening cascades, SAR workflows), follow your institutional protocols; this listing does not include validated dilutions or bioassay conditions.
Biological Roles
Item-specific biological role: None provided; not intended for biological function assignment. For research use only.
General context for this scaffold (no clinical or therapeutic claims):
Piperazine-substituted pyridines are common in medicinal chemistry as cationic, hydrogen-bonding motifs that can modulate solubility and target engagement in enzyme or receptor-binding pockets.
The nitrile group can act as a polar, weakly hydrogen-bond-accepting substituent and occasionally as a reversible electrophile toward strong nucleophiles in proteins; however, specific target interactions are highly structure- and context-dependent and are not defined for this item.
Protonation states: at physiological pH, piperazine nitrogens are typically protonated to some degree, influencing membrane permeability and distribution in biological assays. Exact pKa values and distribution coefficients are not specified for this item.
Use guidance:
If used as a research intermediate or tool compound precursor, confirm purity and counterion identity to avoid confounding biological readouts.
For in vitro assays, prepare fresh DMSO stocks, filter sterilize if required by your protocol, and minimize final DMSO percentage in biological media to avoid solvent effects.
Note: This product is supplied for laboratory research use only and is not intended for diagnostic, therapeutic, or in vivo applications.
Buffer Applications
Not typically applicable: 2-(4-Ethylpiperazino)isonicotinonitrile is a specialized heteroaromatic building block, not a buffering reagent.
Practical notes (if handling in aqueous systems for research):
Aqueous solubility of the free base may be limited; form a water-soluble salt (e.g., hydrochloride) for buffered aqueous work.
Maintain buffers in ranges compatible with amine protonation (approx. pH 5–8) to control solubility and ionization state.
Filter solutions (0.22 µm) to remove particulates before biological or analytical use.
For standard buffering needs, select established buffer systems (PBS, HEPES, MOPS, citrate) appropriate to your assay pH; this compound is not intended as a buffer component.
Green Alternatives
Context: The compound is a nitrogen-rich heteroaromatic building block; the greener focus is on solvents, reagents, and process design rather than on the molecule itself.
Greener solvent choices (literature guidance):
Prefer 2-MeTHF or CPME over THF/diethyl ether for extractions/workups; they offer lower peroxide risk and improved sustainability.
Use ethanol, isopropanol, or water (salt forms) when feasible instead of chlorinated solvents.
For polar aprotic needs, consider Cyrene or propylene carbonate as partial replacements for DMF/DMSO in certain steps, noting reactivity and viscosity tradeoffs.
Greener reagents for key transformations:
Nitrile reduction: transfer hydrogenation (e.g., formic acid/triethylamine with Pd/C) or catalytic hydrogenation can be greener than stoichiometric metal hydrides. Avoid cyanide-generating conditions.
Carbamate/urea formation: CDI or DSC in greener solvents can replace phosgene derivatives.
Process intensification and waste minimization:
Employ telescoped sequences (e.g., SNAr then salt formation) to avoid isolating intermediates.
Implement real-time analytics (PAT/LC-MS) to minimize overuse of reagents and rework.
Tradeoffs:
Biobased solvents (2-MeTHF) may have water content variability; control drying where water-sensitive steps (e.g., imidate formation) are planned.
Alternative polar aprotics (Cyrene) can be less stable under strong base and at high temperatures—verify compatibility.
Selection should follow solvent selection guides (e.g., ACS GCI, Pfizer/J&J) tailored to your specific step chemistry.
Pharmaceutical Uses
Item-specific status: No pharmacopeial designation or excipient role is provided for this item; it is offered for research use only.
General context (no therapeutic claims):
Piperazine-bearing pyridines are frequent intermediates in discovery-stage APIs. This compound may serve as a synthetic intermediate or fragment in structure–activity relationship (SAR) studies and lead optimization projects.
Salt formation with inorganic or organic acids can be used to modulate physicochemical properties (solubility, crystallinity) during development chemistry. Counterion selection (e.g., HCl, sulfate, mesylate) should consider hygroscopicity and stability.
Formulation/development considerations for research samples:
For assay stocks, prepare as the free base in DMSO or as an aqueous salt solution after pH adjustment; verify stability by LC/MS over intended storage intervals.
Avoid non-volatile buffers if material will be analyzed by LC/MS or lyophilized.
Regulatory note: Not for human or veterinary use; not GMP grade. Any scale-up or preclinical development would require separate sourcing and qualification.
Physical Properties
Item-specific specs (Product Data):
Appearance: Not specified for this item; refer to CoA/Spec Sheet.
Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
Not provided for this item (consult CoA/SDS for authoritative values):
Melting point, boiling point, density, refractive index, water content, residual solvents, UV cutoff: Not specified for this item; refer to CoA/Spec Sheet.
General expectations for this compound class (literature/context, not item specifications):
Physical state: piperazine-bearing pyridine nitriles are commonly isolated as crystalline solids or low-melting solids; hygroscopicity can vary with salt form. Free bases may be oils at ambient temperature depending on substituents.
Solubility profile: tertiary amine-containing heteroaromatics typically show good solubility in polar aprotic solvents (DMSO, DMF, NMP) and alcohols; limited solubility in nonpolar hydrocarbons. Protonation with mineral acids affords water-soluble salts.
Basicity: the piperazine nitrogens are basic (two tertiary/secondary-type sites within the ring and one N-ethyl), enabling salt formation; the pyridine nitrogen is weakly basic. Exact pKa values are structure dependent and not specified for this item.
Practical note: for solubility screening in assay or synthesis, start with dry DMSO to 10–100 mM stock, then dilute into aqueous media with surfactant or co-solvent as needed.
Quality and Grades
Item-specific (Product Data):
Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
Interpreting quality for this compound class (general guidance):
For heteroaromatic building blocks used in discovery chemistry, typical quality indicators include assay purity by HPLC/UPLC, NMR identity, residual solvents, water content (KF), and inorganic ash/metals (if catalytic steps were used). When using in SAR or library synthesis, ≥95–98% HPLC purity is commonly targeted.
Low-UV impurity control is important for photometric analytics. If intended for LC/MS workflows, verify the absence of non-volatile buffers and ensure volatility of any counterions (if salt forms are supplied).
Stabilizers: none are typically required for this class; avoid unnecessary additives that could interfere with downstream coupling or salt formation. If a salt form is preferred for handling, confirm counterion identity on the CoA.
Documentation and traceability:
Request the batch-specific CoA for exact assay, impurity profile, residual solvents, and analytical methods.
Lot-to-lot reproducibility is essential for medicinal chemistry; retain reference spectra and chromatograms for internal QC.
Note: Where specific numeric specifications are required for your application (e.g., HPLC area %, residual Pd, water content), consult the CoA/Spec Sheet; item-specific values are not provided here.
Reaction and Applications
Role in synthesis (general/literature context for this scaffold):
Medicinal chemistry building block combining a pyridine nitrile (isonicotinonitrile) with a dialkylated piperazine. Useful for assembling kinase/GPCR-focused libraries and CNS-targeted chemotypes (no clinical claims implied).
The para-nitrile offers a versatile handle for transformations: reduction to primary amine, hydrolysis to amide/acid (vigorous), or participation in nucleophilic additions under activating conditions.
The piperazine tertiary amine enables salt formation, quaternization, urea/carbamate formation (via phosgene equivalents or CDI), and selective acylation on the less hindered nitrogen if differential protection is employed.
Typical application families:
Fragment growth/merging onto heteroaromatic cores via SNAr on activated pyridines (if further substitution is pursued) or cross-couplings when halo derivatives are used upstream.
Late-stage diversification at the nitrile: catalytic hydrogenation (Raney Ni, Pd/C) to primary amine; BH3·THF reductions; or Pinner-type chemistry (alcohol + HCl) to imidates leading to amidines.
Salt screening and SAR: converting the free base to pharmaceutically acceptable salts for solubility/permeability exploration in research settings.
Practical considerations:
Protecting-group strategy: Boc protection of the piperazine can enable selective acylation/alkylation; ensure compatibility with nitrile (Boc stable to mild bases, cleaves in TFA).
Workup/purification: basic compounds often tail on silica—use 1–2% Et3N in eluents or switch to reverse-phase (C18) with volatile modifiers (NH4HCO3).
Analytical: monitor transformations by LC/MS; nitrile-to-amine reductions show +2 mass units and altered retention due to increased polarity.
Reaction Conditions
General conditions from literature precedent for related scaffolds (guidance only; optimize experimentally):
SNAr coupling of 2-halo-4-cyanopyridines with piperazines:
Solvent: DMF, DMSO, or NMP (anhydrous).
Base: K2CO3, Cs2CO3, or DIPEA.
Temperature: 60–120 °C (oil bath or sealed tube/micro-wave 100–150 °C for acceleration).
Time: 2–16 h depending on activation (F > Cl > Br).
Notes: Use excess piperazine or base to suppress bis-arylation; protect one nitrogen (Boc) for selectivity when needed.
Buchwald–Hartwig amination (if aryl halide is less activated):
Catalyst: Pd2(dba)3 or Pd(OAc)2 (1–5 mol%).
Ligand: tBuBrettPhos, XPhos, or RuPhos (2–10 mol%).
Base: NaOtBu or K3PO4.
Solvent: toluene, dioxane, or CPME with cosolvent (tBuOH) where applicable.
Temperature: 80–110 °C; inert atmosphere.
Nitrile reduction to primary amine:
Catalytic hydrogenation: Pd/C or Raney Ni, 5–50 bar H2, MeOH/EtOH, 20–60 °C.
Borane: BH3·THF (1–3 eq), 0–25 °C then reflux as needed; quench cautiously.
Pinner/iminoether formation:
Dry HCl in ROH (EtOH/MeOH), 0–25 °C to form imidate, then amidine formation with amines.
Workup and purification:
Neutralize basic reaction mixtures carefully; partition into appropriate phases; for basic products use 1–2% Et3N in silica eluent or reversed-phase C18 with NH4HCO3.
Expected yields: vary widely (40–85%) depending on method and substitution; confirm by LC/MS and NMR.
Safety: Handle strong bases, hydrogen, and borane reagents under appropriate safety protocols and consult SDS.
Safety and Handling
Item-specific hazard data (Product Data):
Signal Word: Not specified for this item; refer to SDS.
H-Statements: Not specified for this item; refer to SDS.
GHS Classification/Pictograms: Not specified for this item; refer to SDS.
General safety guidance for piperazine-containing heteroaromatic nitriles (context; consult SDS for authoritative instructions):
Likely hazards: organic amines may cause skin/eye irritation and respiratory tract irritation; nitriles and heteroaromatics can present systemic toxicity if ingested or inhaled. Avoid dust/aerosol formation.
PPE: use lab coat, nitrile gloves, and splash goggles. Handle in a fume hood to minimize inhalation exposure.
Incompatibilities: strong oxidizing agents; strong acids/bases may lead to salt formation or decomposition; acylating/alkylating agents may react with amine nitrogens.
First aid (general): in case of skin contact, wash with soap and water. For eye contact, rinse cautiously with water for several minutes and seek medical attention. If inhaled, move to fresh air; if ingested, rinse mouth—do not induce vomiting—seek medical attention.
Spill response: contain solid spills with inert absorbent, avoid dust, and collect for disposal in accordance with local regulations.
Fire safety: treat as combustible organic solid; use CO2, dry chemical, or foam. Combustion may produce NOx and CN-containing fumes; firefighters should wear self-contained breathing apparatus.
Always defer to the product’s SDS and institutional EHS procedures.
Research Use Note: For research use only.
Solvent Selection
Item-specific solubility data: Not specified for this item; refer to CoA/Spec Sheet.
General guidance for tertiary amine heteroaromatic nitriles (literature/context):
Likely good solvents: DMSO, DMF, NMP, MeOH, EtOH, acetonitrile. Moderate in acetone/ethyl acetate. Poor in alkanes and nonpolar ethers.
Aqueous handling: convert to an acid salt (e.g., HCl, mesylate) to enhance water solubility; buffer near neutral pH to mitigate amine protonation state shifts.
Polarity class: polar organic base; expect strong interactions with protic and polar aprotic solvents.
Chromatography: basic analyte—silica gel may cause tailing; add 0.1–2% triethylamine or NH4OH to eluents, or use basic alumina/reversed-phase purification.
When to choose alternatives:
If water compatibility is required, prepare aqueous stocks of a salt form or use co-solvent systems (DMSO/H2O or MeOH/H2O) with surfactant if needed.
For moisture/air-sensitive transformations on the nitrile or piperazine, use rigorously dried aprotic solvents (e.g., anhydrous DMF, THF) and inert gas.
Practical tips:
Begin with a small solubility screening panel (DMSO, MeOH, ACN, DMA) at room temperature and gentle heat (<40–50 °C) if necessary.
Filter through PTFE prior to microplate or HPLC loading to remove particulates.
Storage and Reconstitution
Item-specific (Product Data):
Storage Conditions: Room temperature.
Shipped In: Not specified for this item; refer to CoA/Spec Sheet.
General storage guidance for amine-containing heteroaromatics:
Store tightly sealed in a cool, dry, well-ventilated place away from strong oxidizers and acids. Protect from moisture to prevent salt formation or hydrolysis side reactions.
If provided as a free base, consider storing under inert gas for long-term stability; avoid prolonged exposure to air in humid environments.
For long-term sample integrity, aliquot upon receipt to minimize repeated opening. Record open date and maintain lot-specific QC data.
Reconstitution (research use):
For synthetic use: dissolve in anhydrous polar aprotic solvent (e.g., DMF, DMSO, acetonitrile) under inert atmosphere if water-sensitive transformations are planned.
For assay stocks: prepare in dry DMSO (10–100 mM), then dilute into buffer immediately before use to a final DMSO content typically ≤0.5–1% v/v, as permitted by your assay.
If preparing aqueous solutions, adjust pH with dilute acid to form a soluble salt; filter sterilize through 0.22 µm if sterility is required.
Stability: Specific shelf-life and stability data are not provided for this item; consult the CoA/Spec Sheet and perform periodic QC checks.
InChIKey: Not specified for this item; refer to CoA/Spec Sheet. (Note: provided value appears incomplete in Product Data.)
SMILES: Not specified for this item; refer to CoA/Spec Sheet.
Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
Literature-based structural description (for context; not item specification):
Core scaffold: an isonicotinonitrile (4-cyanopyridine) ring with substitution at the 2-position.
Substituent: a 4-ethylpiperazin-1-yl moiety bound via the piperazine ring nitrogen to C2 of the pyridine.
Functional groups: heteroaromatic pyridine, cyano (nitrile) at the para position (4-position) of the ring, tertiary diamine (piperazine) bearing an ethyl substituent at the distal nitrogen.
2D structural features in words: a six-membered aromatic pyridine ring; at ring position 4 a –C≡N group; at ring position 2 a –N(piperazine–CH2CH3) linkage where the piperazine is a six-membered saturated diamine (–N–CH2–CH2–N–) with the distal nitrogen ethylated.
Stereochemistry: none expected (achiral) based on the name; no stereocenters indicated.
Functional handles and reactivity (general/literature context):
Nitrile at the 4-position of the pyridine allows downstream conversions: reduction to primary amine (catalytic hydrogenation, BH3), hydration/hydrolysis to amide/acid (acidic or basic conditions, often harsh), and Pinner reaction to imidate/amidine derivatives.
Piperazine tertiary amine can be selectively protected (Boc, Cbz) to enable mono-acylation/alkylation. Quaternization provides permanently charged derivatives for SAR.
Pyridine nitrogen can participate in coordination and is weakly basic; it may be quaternized or N-oxidized for further diversification.
Retrosynthetic value:
The molecule fragments into isonicotinonitrile (or a suitably functionalized 2-halo-isonicotinonitrile) and 4-ethylpiperazine; assembly typically via SNAr on an activated 2-chloro/fluoro isonicotinonitrile or transition-metal-catalyzed amination (Buchwald–Hartwig) if a halo-pyridine is used.
Differential protection on piperazine enables modular attachment of side chains before coupling to the pyridine core.
Named/representative transformations:
SNAr on 2-chloro-4-cyanopyridine with piperazine derivatives (base-mediated, polar aprotic solvents).
Buchwald–Hartwig amination on 2-bromo/2-chloro-4-cyanopyridines with Pd catalysts and bulky phosphines.
Pinner reaction on the nitrile to access amidines (acidic alcohol media), followed by further derivatization.
Purification/analysis:
Use basic modifiers in silica chromatography; reversed-phase methods with volatile buffers facilitate salt-removal and LC/MS compatibility.
Target Specificity
Not applicable: This product is a small-molecule chemical building block, not a biological affinity reagent or antibody.
No target, epitope, species reactivity, clone, or isotype information is associated with this item.
Utilizziamo i cookie per garantire il corretto funzionamento del sito web e, ove consentito, per migliorare la tua esperienza. Puoi gestire le tue preferenze in qualsiasi momento nelle Impostazioni. Per saperne di più, consulta la nostra Cookie Policy.
Desidera che le inviamo un messaggio quando avremo sconti disponibili?
Ricordamelo più tardi
Grazie! Controlli la sua casella di posta per confermare.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.